{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:47:54Z","timestamp":1788583674285,"version":"build-2803163510"},"reference-count":296,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Ammonium metabolism represents a critically understudied yet pivotal driver of\u00a0prostate tumorigenesis and tumor microenvironment (TME) remodeling. The\u00a0interplay between tumor metabolic reprogramming and the tumor microenvironment has emerged as a critical frontier in oncology research. While previous studies on prostate cancer metabolism have predominantly focused on lipid metabolism and the Warburg effect, the role of ammonium metabolism, particularly the urea cycle in tumor immune regulation remains insufficiently explored. This metabolic reprogramming constitutes a central node connecting catabolic nutrient breakdown to anabolic biosynthesis by integrating upstream amino acid deamination and transamination reactions with downstream pathways, generating key intermediates including \u03b1-ketoglutarate, coenzyme A, and citrate that concurrently fuel the tricarboxylic acid cycle and macromolecular synthesis. Crucially, oncogenic drivers such as Myc and p53 modulate this flux through epigenetic regulation of core enzymes such as glutaminase, glutamine synthetase and ornithine transcarbamylase, thereby channeling metabolism toward tumor progression. The immunomodulatory consequences manifest through dual mechanisms including TME immunosuppression driven by M2 macrophage polarization and immune evasion mediated via glutathione dependent redox homeostasis disruption. Beyond its established role in modulating redox homeostasis, ammonium metabolic reprogramming may additionally trigger novel cell death modalities such as ferroptosis by GSH\/GPX4 axis. This emerging pathway offers promising therapeutic avenues for prostate cancer intervention. Synthesizing mechanistically validated insights from <jats:italic>in vivo<\/jats:italic> or <jats:italic>in vitro<\/jats:italic> models and clinical trials of ammonium-targeting inhibitors, this review proposes novel therapeutic strategies and candidate biomarkers. Moreover, the unique citrate and polyamine metabolism characteristics of prostate cancer may be impacted by these processes, offering promising avenues for future treatments.<\/jats:p>","DOI":"10.3389\/fonc.2025.1673513","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T04:18:05Z","timestamp":1760588285000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Ammonium metabolism rewiring in the prostate cancer microenvironment: Mechanisms and clinical prospects"],"prefix":"10.3389","volume":"15","author":[{"given":"Zihao","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruizhe","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingliang","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoshan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","article-title":"2022 Update on prostate cancer epidemiology and risk factors\u2014A systematic review","volume":"84","author":"Bergengren","year":"2023","journal-title":"Eur Urol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27175730","article-title":"Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches","volume":"27","author":"Sekhoacha","year":"2022","journal-title":"Molecules"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606220","article-title":"10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer","volume":"375","author":"Hamdy","year":"2016","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35466","article-title":"Epidemiology, treatment patterns, and clinical outcomes in de novo oligometastatic hormone-sensitive prostate cancer","volume":"130","author":"Gong","year":"2024","journal-title":"Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2022.130301","article-title":"Metabolic reprograming of cancer as a therapeutic target","volume":"1867","author":"Furukawa","year":"2023","journal-title":"Biochim Biophys Acta (BBA) - Gen Subj"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15133473","article-title":"Lactate as key metabolite in prostate cancer progression: what are the clinical implications","volume":"15","author":"Chetta","year":"2023","journal-title":"Cancers"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.11712","article-title":"Bone marrow adipocytes promote the Warburg phenotype in metastatic prostate tumors via HIF-1\u03b1 activation","volume":"7","author":"Diedrich","year":"2016","journal-title":"Oncotarget"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-021-01435-5","article-title":"Metabolic reprogramming in prostate cancer","volume":"125","author":"Ahmad","year":"2021","journal-title":"Br J Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716984","article-title":"Durable remissions with ivosidenib in IDH1 -mutated relapsed or refractory AML","volume":"378","author":"DiNardo","year":"2018","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2021.100797","article-title":"Impact of cancer metabolism on therapy resistance - Clinical implications","volume":"59","author":"Gon\u00e7alves","year":"2021","journal-title":"Drug Resist Update"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-1490","article-title":"AKT1 and MYC induce distinctive metabolic fingerprints in human prostate cancer","volume":"74","author":"Priolo","year":"2014","journal-title":"Cancer Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.89","article-title":"The multifaceted roles of fatty acid synthesis in cancer","volume":"16","author":"R\u00f6hrig","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2433","article-title":"The fatty acid synthase inhibitor triclosan: repurposing an anti-microbial agent for targeting prostate cancer","volume":"5","author":"Sadowski","year":"2014","journal-title":"Oncotarget"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217441","article-title":"Metabolic reprogramming, Malignant transformation and metastasis: Lessons from chronic lymphocytic leukaemia and prostate cancer","volume":"611","author":"Hindes","year":"2025","journal-title":"Cancer Lett"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The warburg effect: how does it benefit cancer cells","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3796","article-title":"\u03b1-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming","volume":"18","author":"Liu","year":"2017","journal-title":"Nat Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/nature25465","article-title":"Asparagine bioavailability governs metastasis in a model of breast cancer","volume":"554","author":"Knott","year":"2018","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.ajpath.2011.11.030","article-title":"Integrative molecular profiling reveals asparagine synthetase is a target in castration-resistant prostate cancer","volume":"180","author":"Sircar","year":"2012","journal-title":"Am J Pathol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/bjc.2013.293","article-title":"Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma","volume":"109","author":"Zhang","year":"2013","journal-title":"Br J Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2016.28","article-title":"Loss of asparagine synthetase suppresses the growth of human lung cancer cells by arresting cell cycle at G0\/G1 phase","volume":"23","author":"Xu","year":"2016","journal-title":"Cancer Gene Ther"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-23-2910","article-title":"Asparagine dependency is a targetable metabolic vulnerability in TP53 -altered castration-resistant prostate cancer","volume":"84","author":"Yoo","year":"2024","journal-title":"Cancer Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1038\/s41467-020-15573-6","article-title":"p53-mediated control of aspartate-asparagine homeostasis dictates LKB1 activity and modulates cell survival","volume":"11","author":"Deng","year":"2020","journal-title":"Nat Commun"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-2519","article-title":"Enhanced expression of asparagine synthetase under glucose-deprived conditions protects pancreatic cancer cells from apoptosis induced by glucose deprivation and cisplatin","volume":"67","author":"Cui","year":"2007","journal-title":"Cancer Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-020-0288-x","article-title":"Tumour metabolism and its unique properties in prostate adenocarcinoma","volume":"17","author":"Bader","year":"2020","journal-title":"Nat Rev Urol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2011-1248","article-title":"Abstract 1248: Enhanced glutamine metabolism contributes to docetaxel resistance in DU145 prostate cancer cells","volume":"71","author":"Rajagopalan","year":"2011","journal-title":"Cancer Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1161\/res.133.suppl_1.P3193","article-title":"Abstract P3193: cardiac glutamine metabolism as NAD+ Generating pathway during chronic hypoxia","volume":"133","author":"Menendez-Montes","year":"2023","journal-title":"Circ Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2009.358","article-title":"Q\u2019s next: the diverse functions of glutamine in metabolism, cell biology and cancer","volume":"29","author":"DeBerardinis","year":"2010","journal-title":"Oncogene"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-0080","article-title":"Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolism","volume":"73","author":"Fendt","year":"2013","journal-title":"Cancer Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3483","article-title":"Cancer metabolism: fatty acid oxidation in the limelight","volume":"13","author":"Carracedo","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"B31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0006-2952(95)02157-4","article-title":"Glutathione and glutathione S-transferase in benign and Malignant prostate cell lines and prostate tissues","volume":"51","author":"Canada","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s11307-014-0756-x","article-title":"Accumulation of trans-1-amino-3-[(18)F]fluorocyclobutanecarboxylic acid in prostate cancer due to androgen-induced expression of amino acid transporters","volume":"16","author":"Okudaira","year":"2014","journal-title":"Mol Imaging Biol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/mrm.25360","article-title":"Probing treatment response of glutaminolytic prostate cancer cells to natural drugs with hyperpolarized [5-(13) C]glutamine","volume":"73","author":"Canap\u00e8","year":"2015","journal-title":"Magn Reson Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20181826","article-title":"Inhibition of GLS suppresses proliferation and promotes apoptosis in prostate cancer","volume":"39","author":"Zhang","year":"2019","journal-title":"Biosci Rep"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-023-00971-9","article-title":"Targeting glutamine metabolism as a therapeutic strategy for cancer","volume":"55","author":"Jin","year":"2023","journal-title":"Exp Mol Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/nature07823","article-title":"c-Myc suppression of miR-23a\/b enhances mitochondrial glutaminase expression and glutamine metabolism","volume":"458","author":"Gao","year":"2009","journal-title":"Nature"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1203244109","article-title":"Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC","volume":"109","author":"Liu","year":"2012","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2018.08.069","article-title":"c-Myc-driven glycolysis via TXNIP suppression is dependent on glutaminase-MondoA axis in prostate cancer","volume":"504","author":"Qu","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-16-0480","article-title":"Glutamine transporters are targets of multiple oncogenic signaling pathways in prostate cancer","volume":"15","author":"White","year":"2017","journal-title":"Mol Cancer Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.7150\/thno.58655","article-title":"GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy","volume":"11","author":"Mukha","year":"2021","journal-title":"Theranostics"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1172\/JCI76029","article-title":"Coactivator SRC-2-dependent metabolic reprogramming mediates prostate cancer survival and metastasis","volume":"125","author":"Dasgupta","year":"2015","journal-title":"J Clin Invest"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.10782","article-title":"PDHA1 gene knockout in prostate cancer cells results in metabolic reprogramming towards greater glutamine dependence","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/path.5665","article-title":"Inhibition of guanosine monophosphate synthetase (GMPS) blocks glutamine metabolism and prostate cancer growth","volume":"254","author":"Wang","year":"2021","journal-title":"J Pathol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-021-02155-z","article-title":"Targeting glutamine metabolism network for the treatment of therapy-resistant prostate cancer","volume":"41","author":"Xu","year":"2022","journal-title":"Oncogene"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-0749","article-title":"Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading","volume":"68","author":"Albers","year":"2008","journal-title":"Cancer Res"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11010-005-8841-8","article-title":"Why do tumour cells glycolyse?\u201d: from glycolysis through citrate to lipogenesis","volume":"280","author":"Costello","year":"2005","journal-title":"Mol Cell Biochem"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(20)82128-0","article-title":"The pathways of glutamate and glutamine oxidation by tumor cell mitochondria. Role of mitochondrial NAD(P)+-dependent Malic enzyme","volume":"259","author":"Moreadith","year":"1984","journal-title":"J Biol Chem"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0709747104","article-title":"Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis","volume":"104","author":"DeBerardinis","year":"2007","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113873","article-title":"Arglabin, an EGFR receptor tyrosine kinase inhibitor, suppresses proliferation and induces apoptosis in prostate cancer cells","volume":"156","author":"El Gaafary","year":"2022","journal-title":"Biomedicine Pharmacotherapy"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(00)00256-4","article-title":"Role of nitric oxide in carcinogenesis and tumour progression","volume":"2","author":"Lala","year":"2001","journal-title":"Lancet Oncol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.4103\/aja202363","article-title":"Lipid metabolism, amino acid metabolism, and prostate cancer: a crucial metabolic journey","volume":"26","author":"Chen","year":"2024","journal-title":"Asian J Andrology"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2021.11.001","article-title":"The regulatory and modulatory roles of TRP family channels in Malignant tumors and relevant therapeutic strategies","volume":"12","author":"Zhong","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2011.244","article-title":"Serotonin synthesis and metabolism-related molecules in a human prostate cancer cell line","volume":"2","author":"Shinka","year":"2011","journal-title":"Oncol Lett"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2014.05.001","article-title":"Serum kynurenine\/tryptophan ratio is not a potential marker for detecting prostate cancer","volume":"47","author":"Rodr\u00edguez-Blanco","year":"2014","journal-title":"Clin Biochem"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-022-00313-z","article-title":"SNHG3 could promote prostate cancer progression through reducing methionine dependence of PCa cells","volume":"27","author":"Wang","year":"2022","journal-title":"Cell Mol Biol Lett"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.14254","article-title":"Oral dosing of recombinant methioninase is associated with a 70% Drop in PSA in a patient with bone-metastatic prostate cancer and 50% Reduction in circulating methionine in a high-stage ovarian cancer patient","volume":"40","author":"Han","year":"2020","journal-title":"Anticancer Res"},{"key":"B57","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cellsig.2011.08.010","article-title":"Proline-rich Akt substrate of 40kDa (PRAS40): a novel downstream target of PI3k\/Akt signaling pathway","volume":"24","author":"Wang","year":"2012","journal-title":"Cell Signal"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2007.12.023","article-title":"Specific N-terminal mutations in the human androgen receptor induce cytotoxicity","volume":"30","author":"Funderburk","year":"2009","journal-title":"Neurobiol Aging"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1002\/pros.2990210307","article-title":"Dose-dependent induction of ornithine decarboxylase and S-adenosyl-methionine decarboxylase activity by testosterone in the accessory sex organs of male rats","volume":"21","author":"Fj\u00f6sne","year":"1992","journal-title":"Prostate"},{"key":"B60","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1210\/mend-3-1-68","article-title":"High level, cell-specific expression of ornithine decarboxylase transcripts in rat genitourinary tissues","volume":"3","author":"Blackshear","year":"1989","journal-title":"Mol Endocrinol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1002\/pros.10052","article-title":"Androgen regulation of spermidine synthase expression in the rat prostate","volume":"50","author":"Cyriac","year":"2002","journal-title":"Prostate"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1210\/endo.130.3.1537280","article-title":"Comparison of androgen regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase gene expression in rodent kidney and accessory sex organs","volume":"130","author":"Crozat","year":"1992","journal-title":"Endocrinology"},{"key":"B63","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1042\/BJ20021779","article-title":"Genomic identification and biochemical characterization of the mammalian polyamine oxidase involved in polyamine back-conversion","volume":"370","author":"Vujcic","year":"2003","journal-title":"Biochem J"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1042\/bst0310375","article-title":"Polyamines and prostatic cancer","volume":"31","author":"Schipper","year":"2003","journal-title":"Biochem Soc Trans"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/nm1095-1040","article-title":"Identification of an endogenous inhibitor of prostatic carcinoma cell growth","volume":"1","author":"Smith","year":"1995","journal-title":"Nat Med"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20031327","article-title":"A perspective of polyamine metabolism","volume":"376","author":"Wallace","year":"2003","journal-title":"Biochem J"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.16.7804","article-title":"The ornithine decarboxylase gene is a transcriptional target of c-Myc","volume":"90","author":"Bello-Fernandez","year":"1993","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3390\/medsci6010003","article-title":"Polyamine-targeted therapy for BRAF mutant melanoma tumors","volume":"6","author":"Peters","year":"2018","journal-title":"Med Sci (Basel)"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3390\/medsci6040089","article-title":"Antizyme inhibitors in polyamine metabolism and beyond: physiopathological implications","volume":"6","author":"Ramos-Molina","year":"2018","journal-title":"Med Sci"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-011-1033-9","article-title":"Inducible expression of antizyme 1 in prostate cancer cell lines after lentivirus mediated gene transfer","volume":"42","author":"Pietil\u00e4","year":"2012","journal-title":"Amino Acids"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1002\/pros.2990240307","article-title":"Isocitric and citric acid in human prostatic and seminal fluid: implications for prostatic metabolism and secretion","volume":"24","author":"Kavanagh","year":"1994","journal-title":"Prostate"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/S0005-2728(05)80026-X","article-title":"Mitochondrial substrate carriers","volume":"1101","author":"Palmieri","year":"1992","journal-title":"Biochim Biophys Acta"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.11.5779","article-title":"Sequence and functional characterization of a renal sodium\/dicarboxylate cotransporter","volume":"270","author":"Pajor","year":"1995","journal-title":"J Biol Chem"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.33.20972","article-title":"Characterization of a rat Na+-dicarboxylate cotransporter","volume":"273","author":"Chen","year":"1998","journal-title":"J Biol Chem"},{"key":"B75","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/bies.080137","article-title":"Citrate transport and metabolism in mammalian cells: Prostate epithelial cells and prostate cancer","volume":"31","author":"Mycielska","year":"2009","journal-title":"BioEssays"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.03.016","article-title":"Differential glutamate metabolism in proliferating and quiescent mammary epithelial cells","volume":"23","author":"Coloff","year":"2016","journal-title":"Cell Metab"},{"key":"B77","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s44303-025-00100-3","article-title":"Imaging the uptake and metabolism of glutamine in prostate tumor models using CEST MRI","volume":"3","author":"Hodo","year":"2025","journal-title":"NPJ Imaging"},{"key":"B78","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s13046-025-03430-7","article-title":"Targeting glutamine metabolism as a potential target for cancer treatment","volume":"44","author":"Zou","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"B79","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.cmet.2022.11.013","article-title":"Microenvironmental ammonia enhances T cell exhaustion in colorectal cancer","volume":"35","author":"Bell","year":"2023","journal-title":"Cell Metab"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-022-00568-y","article-title":"Ammonia stimulates SCAP\/Insig dissociation and SREBP-1 activation to promote lipogenesis and tumour growth","volume":"4","author":"Cheng","year":"2022","journal-title":"Nat Metab"},{"key":"B81","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrc.2016.114","article-title":"From Krebs to clinic: glutamine metabolism to cancer therapy","volume":"16","author":"Altman","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/ncb3272","article-title":"Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma","volume":"17","author":"Tardito","year":"2015","journal-title":"Nat Cell Biol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1126\/science.aam9305","article-title":"Metabolic recycling of ammonia via glutamate dehydrogenase supports breast cancer biomass","volume":"358","author":"Spinelli","year":"2017","journal-title":"Science"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2125","article-title":"Matrix metalloproteinases and the regulation of tissue remodelling","volume":"8","author":"Page-McCaw","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00776","article-title":"Proline metabolism in tumor growth and metastatic progression, front","volume":"10","author":"D\u2019Aniello","year":"2020","journal-title":"Oncol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2017.11.010","article-title":"Hypoxia inducible factors modify collagen I fibers in MDA-MB-231 triple negative breast cancer xenografts","volume":"20","author":"Goggins","year":"2018","journal-title":"Neoplasia"},{"key":"B87","doi-asserted-by":"publisher","first-page":"4456","DOI":"10.1038\/s41467-018-06893-9","article-title":"Collagen prolyl 4-hydroxylase 1 is essential for HIF-1\u03b1 stabilization and TNBC chemoresistance","volume":"9","author":"Xiong","year":"2018","journal-title":"Nat Commun"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0810199105","article-title":"Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction, Proc","volume":"105","author":"Wise","year":"2008","journal-title":"Natl Acad Sci USA"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1001006107","article-title":"Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function","volume":"107","author":"Hu","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2010.08.009","article-title":"Targeting mitochondrial glutaminase activity inhibits oncogenic transformation","volume":"18","author":"Wang","year":"2010","journal-title":"Cancer Cell"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0b013e32834d816a","article-title":"Altered cancer cell metabolism in gliomas with mutant IDH1 or IDH2","volume":"24","author":"Borodovsky","year":"2012","journal-title":"Curr Opin Oncol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076581","article-title":"STAT1 regulates human glutaminase 1 promoter activity through multiple binding sites in HIV-1 infected macrophages","volume":"8","author":"Zhao","year":"2013","journal-title":"PloS One"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1116573109","article-title":"Structural basis for the allosteric inhibitory mechanism of human kidney-type glutaminase (KGA) and its regulation by Raf-Mek-Erk signaling in cancer cell metabolism","volume":"109","author":"Thangavelu","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1038\/nature12040","article-title":"Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway","volume":"496","author":"Son","year":"2013","journal-title":"Nature"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.84","article-title":"Oxygen availability and metabolic adaptations","volume":"16","author":"Nakazawa","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R117.799973","article-title":"Oxygen availability and metabolic reprogramming in cancer","volume":"292","author":"Xie","year":"2017","journal-title":"J Biol Chem"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.738961","article-title":"Counteracting action of curcumin on high glucose-induced chemoresistance in hepatic carcinoma cells","volume":"11","author":"Soni","year":"2021","journal-title":"Front Oncol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.08.028","article-title":"HIF-1-mediated suppression of acyl-coA dehydrogenases and fatty acid oxidation is critical for cancer progression","volume":"8","author":"Huang","year":"2014","journal-title":"Cell Rep"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.08.056","article-title":"Fatty acid uptake and lipid storage induced by HIF-1\u03b1 Contribute to cell growth and survival after hypoxia-reoxygenation","volume":"9","author":"Bensaad","year":"2014","journal-title":"Cell Rep"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.31132","article-title":"Inhibition of intracellular lipolysis promotes human cancer cell adaptation to hypoxia","volume":"6","author":"Zhang","year":"2017","journal-title":"eLife"},{"key":"B101","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13059-023-02931-y","article-title":"YY1 lactylation in microglia promotes angiogenesis through transcription activation-mediated upregulation of FGF2","volume":"24","author":"Wang","year":"2023","journal-title":"Genome Biol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13059-021-02308-z","article-title":"Histone lactylation drives oncogenesis by facilitating m6A reader protein YTHDF2 expression in ocular melanoma","volume":"22","author":"Yu","year":"2021","journal-title":"Genome Biol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.semcancer.2020.12.002","article-title":"Metabolic regulation of prostate cancer heterogeneity and plasticity","volume":"82","author":"Peitzsch","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2019.05.014","article-title":"c-myc overexpression promotes oral cancer cell proliferation and migration by enhancing glutaminase and glutamine synthetase activity","volume":"358","author":"Wang","year":"2019","journal-title":"Am J Med Sci"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2015.09.025","article-title":"Oncogenic myc induces expression of glutamine synthetase through promoter demethylation","volume":"22","author":"Bott","year":"2015","journal-title":"Cell Metab"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjaf007","article-title":"Novel roles of ammonia in physiology and cancer","volume":"17","author":"Chen","year":"2025","journal-title":"J Mol Cell Biol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1186\/s12935-021-02121-5","article-title":"Role of glutamine and its metabolite ammonia in crosstalk of cancer-associated fibroblasts and cancer cells","volume":"21","author":"Li","year":"2021","journal-title":"Cancer Cell Int"},{"key":"B108","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.molcel.2016.05.029","article-title":"Interplay between metabolism and epigenetics: A nuclear adaptation to environmental changes","volume":"62","author":"Etchegaray","year":"2016","journal-title":"Mol Cell"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1038\/nature13981","article-title":"Intracellular \u03b1-ketoglutarate maintains the pluripotency of embryonic stem cells","volume":"518","author":"Carey","year":"2015","journal-title":"Nature"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1006\/mgme.1999.2857","article-title":"Glutamine, as a precursor of glutathione, and oxidative stress","volume":"67","author":"Amores-S\u00e1nchez","year":"1999","journal-title":"Mol Genet Metab"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217258","article-title":"Macroautophagy\/autophagy promotes resistance to KRASG12D-targeted therapy through glutathione synthesis","volume":"604","author":"Han","year":"2024","journal-title":"Cancer Lett"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2022.113471","article-title":"Complex molecular mechanism of ammonia-induced apoptosis in chicken peripheral blood lymphocytes: miR-27b-3p, heat shock proteins, immunosuppression, death receptor pathway, and mitochondrial pathway","volume":"236","author":"Zhang","year":"2022","journal-title":"Ecotoxicology Environ Saf"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.2174\/0115665232301222240603100840","article-title":"The role and treatment strategies of ammonia-related metabolism inTumor microenvironment","volume":"25","author":"Ye","year":"2024","journal-title":"CGT"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.55185","article-title":"The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy","volume":"9","author":"Lim","year":"2020","journal-title":"eLife"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-16-0244","article-title":"Filling the tank: keeping antitumor T cells metabolically fit for the long haul","volume":"4","author":"Delgoffe","year":"2016","journal-title":"Cancer Immunol Res"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00541-y","article-title":"Metabolic barriers to cancer immunotherapy","volume":"21","author":"DePeaux","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1186539","article-title":"Crosstalk between arginine, glutamine, and the branched chain amino acid metabolism in the tumor microenvironment, Front","volume":"13","author":"Wetzel","year":"2023","journal-title":"Oncol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.132975","article-title":"Mitochondrial arginase-2 is a cell\u2212autonomous regulator of CD8+ T cell function and antitumor efficacy","volume":"4","author":"L\u00edndez","year":"2019","journal-title":"JCI Insight"},{"key":"B119","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2016.09.031","article-title":"L-arginine modulates T cell metabolism and enhances survival and anti-tumor activity","volume":"167","author":"Geiger","year":"2016","journal-title":"Cell"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0697-7","article-title":"Autophagy maintains tumour growth through circulating arginine","volume":"563","author":"Poillet-Perez","year":"2018","journal-title":"Nature"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1159\/000495382","article-title":"Arginine-depleting enzymes \u2013 an increasingly recognized treatment strategy for therapy-refractory Malignancies","volume":"51","author":"Riess","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2556","article-title":"Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation","volume":"14","author":"Sinclair","year":"2013","journal-title":"Nat Immunol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1016\/j.cell.2018.10.001","article-title":"Distinct regulation of th17 and th1 cell differentiation by glutaminase-dependent metabolism","volume":"175","author":"Johnson","year":"2018","journal-title":"Cell"},{"key":"B124","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.immuni.2014.04.007","article-title":"Inflammatory T cell responses rely on amino acid transporter ASCT2 facilitation of glutamine uptake and mTORC1 kinase activation","volume":"40","author":"Nakaya","year":"2014","journal-title":"Immunity"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1620433114","article-title":"Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity","volume":"114","author":"Chamoto","year":"2017","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of cancer progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"key":"B127","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ccell.2017.08.004","article-title":"Enhancing CD8+ T cell fatty acid catabolism within a metabolically challenging tumor microenvironment increases the efficacy of melanoma immunotherapy","volume":"32","author":"Zhang","year":"2017","journal-title":"Cancer Cell"},{"key":"B128","doi-asserted-by":"publisher","first-page":"6692","DOI":"10.1038\/ncomms7692","article-title":"PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation","volume":"6","author":"Patsoukis","year":"2015","journal-title":"Nat Commun"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.05.016","article-title":"Posttranscriptional control of T cell effector function by aerobic glycolysis","volume":"153","author":"Chang","year":"2013","journal-title":"Cell"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.11.6752","article-title":"The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor \u03b6-chain and induce a regulatory phenotype in naive T cells","volume":"176","author":"Fallarino","year":"2006","journal-title":"J Immunol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.semcdb.2019.05.012","article-title":"Therapeutic targeting of glutaminolysis as an essential strategy to combat cancer","volume":"98","author":"Mat\u00e9s","year":"2020","journal-title":"Semin Cell Dev Biol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1126\/science.1073514","article-title":"Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase","volume":"297","author":"Munn","year":"2002","journal-title":"Science"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1038\/nm934","article-title":"Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase","volume":"9","author":"Uyttenhove","year":"2003","journal-title":"Nat Med"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1172\/JCI31911","article-title":"Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase, J","volume":"117","author":"Sharma","year":"2007","journal-title":"Clin Invest"},{"key":"B135","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1016\/j.celrep.2019.08.034","article-title":"T cell activation depends on extracellular alanine","volume":"28","author":"Ron-Harel","year":"2019","journal-title":"Cell Rep"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2011.09.021","article-title":"The transcription factor myc controls metabolic reprogramming upon T lymphocyte activation","volume":"35","author":"Wang","year":"2011","journal-title":"Immunity"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1501756","article-title":"Restricting glutamine or glutamine-dependent purine and pyrimidine syntheses promotes human T cells with high FOXP3 expression and regulatory properties","volume":"196","author":"Metzler","year":"2016","journal-title":"J Immunol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"ra97","DOI":"10.1126\/scisignal.aab2610","article-title":"Glutamine-dependent \u03b1-ketoglutarate production regulates the balance between T helper 1 cell and regulatory T cell generation","volume":"8","author":"Klysz","year":"2015","journal-title":"Sci Signal"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1038\/nature23475","article-title":"Metabolic control of TH17 and induced Treg cell balance by an epigenetic mechanism","volume":"548","author":"Xu","year":"2017","journal-title":"Nature"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3439","article-title":"Glucose and glutamine fuel protein O-GlcNAcylation to control T cell self-renewal and Malignancy","volume":"17","author":"Swamy","year":"2016","journal-title":"Nat Immunol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.21330","article-title":"Glycolysis and glutaminolysis cooperatively control T cell function by limiting metabolite supply to N-glycosylation","volume":"6","author":"Araujo","year":"2017","journal-title":"eLife"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1126\/science.aav2588","article-title":"Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion","volume":"366","author":"Leone","year":"2019","journal-title":"Science"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1303218","article-title":"Ammonia drives dendritic cells into dysfunction","volume":"193","author":"Luo","year":"2014","journal-title":"J Immunol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-2826","article-title":"Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism","volume":"69","author":"Norian","year":"2009","journal-title":"Cancer Res"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.154089","article-title":"Metabolic reprogramming during hyperammonemia targets mitochondrial function and postmitotic senescence","volume":"6","author":"Kumar","year":"2021","journal-title":"JCI Insight"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-024-01503-x","article-title":"Ammonia-induced lysosomal and mitochondrial damage causes cell death of effector CD8+ T cells","volume":"26","author":"Zhang","year":"2024","journal-title":"Nat Cell Biol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2020.122605","article-title":"Cooperative application of transcriptomics and ceRNA hypothesis: LncRNA-107052630\/miR-205a\/G0S2 crosstalk is involved in ammonia-induced intestinal apoptotic injury in chicken","volume":"396","author":"Wang","year":"2020","journal-title":"J Hazardous Materials"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1002\/tox.23153","article-title":"Arecoline induces heart injure via Fas\/Fas ligand apoptotic pathway in heart of Sprague\u2013Dawley rat","volume":"36","author":"Lin","year":"2021","journal-title":"Environ Toxicol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1016\/j.archoralbio.2019.05.009","article-title":"The role of Wnt7B in the mediation of dentinogenesis via the ERK1\/2 pathway","volume":"104","author":"Chen","year":"2019","journal-title":"Arch Oral Biol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.36","article-title":"Microbiota in T-cell homeostasis and inflammatory diseases","volume":"49","author":"Lee","year":"2017","journal-title":"Exp Mol Med"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1016\/j.aquaculture.2020.735944","article-title":"Dietary menthol essential oil enhanced the growth performance, digestive enzyme activity, immune-related genes, and resistance against acute ammonia exposure in Nile tilapia (Oreochromis niloticus)","volume":"530","author":"Magouz","year":"2021","journal-title":"Aquaculture"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2021.112833","article-title":"Heat shock proteins took part in oxidative stress-mediated inflammatory injury via NF-\u03baB pathway in excess manganese-treated chicken livers","volume":"226","author":"Liu","year":"2021","journal-title":"Ecotoxicology Environ Saf"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1111\/febs.15531","article-title":"A guide to plasma membrane solute carrier proteins","volume":"288","author":"Pizzagalli","year":"2021","journal-title":"FEBS J"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-003-1192-y","article-title":"The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteins","volume":"447","author":"Hediger","year":"2004","journal-title":"Pflugers Archiv Eur J Physiol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2015.12.017","article-title":"Glutamine transporters in mammalian cells and their functions in physiology and cancer","volume":"1863","author":"Bhutia","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"B156","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.pharmthera.2008.09.005","article-title":"Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond","volume":"121","author":"Ganapathy","year":"2009","journal-title":"Pharmacol Ther"},{"key":"B157","article-title":"L-type amino acid transport and cancer: targeting the mTORC1 pathway to inhibit neoplasia","volume":"5","author":"Wang","year":"2015","journal-title":"Am J Cancer Res"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2012.12.006","article-title":"The small SLC43 family: facilitator system l amino acid transporters and the orphan EEG1","volume":"34","author":"Bodoy","year":"2013","journal-title":"Mol Aspects Med"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-1821","article-title":"Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progression","volume":"71","author":"Wang","year":"2011","journal-title":"Cancer Res"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19030907","article-title":"Amino acid transporters and glutamine metabolism in breast cancer","volume":"19","author":"Cha","year":"2018","journal-title":"IJMS"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201403009","article-title":"The general amino acid control pathway regulates mTOR and autophagy during serum\/glutamine starvation","volume":"206","author":"Chen","year":"2014","journal-title":"J Cell Biol"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076754","article-title":"NAGS, CPS1, and SLC25A13 (Citrin) at the crossroads of arginine and pyrimidines metabolism in tumor cells","volume":"24","author":"Owusu-Ansah","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202402703","article-title":"Loss of carbamoyl phosphate synthetase 1 potentiates hepatocellular carcinoma metastasis by reducing aspartate level","volume":"11","author":"Chen","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101728","article-title":"Targeting NAT10 inhibits osteosarcoma progression via ATF4\/ASNS-mediated asparagine biosynthesis","volume":"5","author":"Zou","year":"2024","journal-title":"Cell Rep Med"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2024.101952","article-title":"Amino acid transporters within the solute carrier superfamily: Underappreciated proteins and novel opportunities for cancer therapy","volume":"84","author":"Hushmandi","year":"2024","journal-title":"Mol Metab"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2023.139716","article-title":"Low-dose antimony exposure promotes prostate cancer proliferation by inhibiting ferroptosis via activation of the Nrf2-SLC7A11-GPX4 pathway","volume":"339","author":"Shi","year":"2023","journal-title":"Chemosphere"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.100915","article-title":"Identification of AR-V7 downstream genes commonly targeted by AR\/AR-V7 and specifically targeted by AR-V7 in castration resistant prostate cancer","volume":"14","author":"Sugiura","year":"2021","journal-title":"Trans Oncol"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2015.11.071","article-title":"Up-regulation of LAT1 during antiandrogen therapy contributes to progression in prostate cancer cells","volume":"195","author":"Xu","year":"2016","journal-title":"J Urol"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12071814","article-title":"Human prostate cancer is characterized by an increase in urea cycle metabolites","volume":"12","author":"Franko","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B170","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s12964-025-02328-3","article-title":"Urea cycle dysregulation: a new frontier in cancer metabolism and immune evasion","volume":"23","author":"Shou","year":"2025","journal-title":"Cell Commun Signal"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2020.11.056","article-title":"Inhibition of HIF-1\u03b1\/EP4 axis by hyaluronate-trimethyl chitosan-SPION nanoparticles markedly suppresses the growth and development of cancer cells","volume":"167","author":"Karpisheh","year":"2021","journal-title":"Int J Biol Macromol"},{"key":"B172","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jconrel.2016.12.012","article-title":"CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice","volume":"246","author":"Jadidi-Niaragh","year":"2017","journal-title":"J Controlled Release"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2019.106338","article-title":"Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer","volume":"144","author":"Karpisheh","year":"2019","journal-title":"Prostaglandins Other Lipid Mediators"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2020.153247","article-title":"EP4 receptor as a novel promising therapeutic target in colon cancer","volume":"216","author":"Karpisheh","year":"2020","journal-title":"Pathol - Res Pract"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-015-4004-z","article-title":"Myeloid-derived suppressor cells in B cell Malignancies","volume":"36","author":"Yazdani","year":"2015","journal-title":"Tumour Biol"},{"key":"B176","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1159\/000541881","article-title":"The immune microenvironment in prostate cancer: A comprehensive review","volume":"103","author":"Novysedlak","year":"2024","journal-title":"Oncology"},{"key":"B177","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40880-017-0198-3","article-title":"Immune mediators in the tumor microenvironment of prostate cancer","volume":"36","author":"Dai","year":"2017","journal-title":"Chin J Cancer"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.3390\/cells11050768","article-title":"New immunometabolic strategy based on cell type-specific metabolic reprogramming in the tumor immune microenvironment","volume":"11","author":"Sung","year":"2022","journal-title":"Cells"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-23-0519","article-title":"Obesogenic high-fat diet and MYC cooperate to promote lactate accumulation and tumor microenvironment remodeling in prostate cancer","volume":"84","author":"Boufaied","year":"2024","journal-title":"Cancer Res"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1713","article-title":"Downregulation of MCT 4 for lactate exchange promotes the cytotoxicity of NK cells in breast carcinoma","volume":"7","author":"Long","year":"2018","journal-title":"Cancer Med"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2017.188","article-title":"Tumor cell-derived lactate induces TAZ-dependent upregulation of PD-L1 through GPR81 in human lung cancer cells","volume":"36","author":"Feng","year":"2017","journal-title":"Oncogene"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12286","article-title":"G-protein-coupled receptor 81 promotes a Malignant phenotype in breast cancer through angiogenic factor secretion","volume":"7","author":"Lee","year":"2016","journal-title":"Oncotarget"},{"key":"B184","doi-asserted-by":"publisher","first-page":"e12107","DOI":"10.1371\/journal.pone.0012107","article-title":"Androgen-regulated expression of arginase 1, arginase 2 and interleukin-8 in human prostate cancer","volume":"5","author":"Gannon","year":"2010","journal-title":"PloS One"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.22.19.6681-6688.2002","article-title":"The GCN2 eIF2alpha kinase is required for adaptation to amino acid deprivation in mice","volume":"22","author":"Zhang","year":"2002","journal-title":"Mol Cell Biol"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0735876100","article-title":"Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox","volume":"100","author":"Lee","year":"2003","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.9.4561","article-title":"Translational control of inducible nitric oxide synthase by IL-13 and arginine availability in inflammatory macrophages","volume":"171","author":"El-Gayar","year":"2003","journal-title":"J Immunol"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.160.12.5729","article-title":"Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3\/STAT5 signaling pathway","volume":"160","author":"Bingisser","year":"1998","journal-title":"J Immunol"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.2.689","article-title":"Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism","volume":"168","author":"Mazzoni","year":"2002","journal-title":"J Immunol"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M009781200","article-title":"Activation of cGMP-dependent protein kinase Ibeta inhibits interleukin 2 release and proliferation of T cell receptor-stimulated human peripheral T cells","volume":"276","author":"Fischer","year":"2001","journal-title":"J Biol Chem"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.9.4809","article-title":"Nitric oxide regulation of human peripheral blood mononuclear cells: critical time dependence and selectivity for cytokine versus chemokine expression","volume":"171","author":"Macphail","year":"2003","journal-title":"J Immunol"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1038\/nri1668","article-title":"Regulation of immune responses by L-arginine metabolism","volume":"5","author":"Bronte","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2009.00291.x","article-title":"Arginase: an emerging key player in the mammalian immune system","volume":"158","author":"Munder","year":"2009","journal-title":"Br J Pharmacol"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25179275","article-title":"Prostate cancer\u2019s silent partners: fibroblasts and their influence on glutamine metabolism manipulation","volume":"25","author":"H\u00f6nscheid","year":"2024","journal-title":"IJMS"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.3390\/cells12050802","article-title":"Cancer-associated fibroblast: role in prostate cancer progression to metastatic disease and therapeutic resistance","volume":"12","author":"Bedeschi","year":"2023","journal-title":"Cells"},{"key":"B196","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.cmet.2016.10.011","article-title":"Targeting stromal glutamine synthetase in tumors disrupts tumor microenvironment-regulated cancer cell growth","volume":"24","author":"Yang","year":"2016","journal-title":"Cell Metab"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1101\/sqb.2016.81.030981","article-title":"Autophagy, metabolism, and cancer","volume":"81","author":"Guo","year":"2016","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"B198","doi-asserted-by":"publisher","first-page":"ra24","DOI":"10.1126\/scisignal.2002739","article-title":"Chronic activation of mTOR complex 1 is sufficient to cause hepatocellular carcinoma in mice","volume":"5","author":"Menon","year":"2012","journal-title":"Sci Signal"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.4161\/cc.9.6.11035","article-title":"The AMPK-FoxO3A axis as a target for cancer treatment","volume":"9","author":"Chiacchiera","year":"2010","journal-title":"Cell Cycle"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1038\/nature22359","article-title":"CPS1 maintains pyrimidine pools and DNA synthesis in KRAS\/LKB1-mutant lung cancer cells","volume":"546","author":"Kim","year":"2017","journal-title":"Nature"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.5114\/ceh.2017.68833","article-title":"Ammonia-induced mitochondrial dysfunction and energy metabolism disturbances in isolated brain and liver mitochondria, and the effect of taurine administration: relevance to hepatic encephalopathy treatment","volume":"3","author":"Niknahad","year":"2017","journal-title":"Ceh"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1002\/cbin.11489","article-title":"PSPH induces cell autophagy and promotes cell proliferation and invasion in the hepatocellular carcinoma cell line Huh7 via the AMPK\/mTOR\/ULK1 signaling pathway","volume":"45","author":"Zhang","year":"2021","journal-title":"Cell Biol Int"},{"key":"B203","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.semcancer.2019.03.002","article-title":"Ferroptosis is a type of autophagy-dependent cell death","volume":"66","author":"Zhou","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"B204","doi-asserted-by":"publisher","first-page":"16130","DOI":"10.1038\/s41598-019-52513-x","article-title":"Extracellular vesicles from endothelial progenitor cells prevent steroid-induced osteoporosis by suppressing the ferroptotic pathway in mouse osteoblasts based on bioinformatics evidence","volume":"9","author":"Lu","year":"2019","journal-title":"Sci Rep"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.02523","article-title":"Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis","volume":"3","author":"Dixon","year":"2014","journal-title":"Elife"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1038\/nature05859","article-title":"RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels","volume":"447","author":"Yagoda","year":"2007","journal-title":"Nature"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0000000000000276","article-title":"Metabolic targets for potential prostate cancer therapeutics","volume":"28","author":"Twum-Ampofo","year":"2016","journal-title":"Curr Opin Oncol"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b00961","article-title":"Overview of the development of glutaminase inhibitors: achievements and future directions","volume":"62","author":"Xu","year":"2019","journal-title":"J Med Chem"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.nu.15.070195.001025","article-title":"Regulation of glutaminase activity and glutamine metabolism","volume":"15","author":"Curthoys","year":"1995","journal-title":"Annu Rev Nutr"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1172\/JCI69600","article-title":"Glutamine and cancer: cell biology, physiology, and clinical opportunities","volume":"123","author":"Hensley","year":"2013","journal-title":"J Clin Invest"},{"key":"B211","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.trecan.2021.04.003","article-title":"Enhancing the efficacy of glutamine metabolism inhibitors in cancer therapy","volume":"7","author":"Yang","year":"2021","journal-title":"Trends Cancer"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1002459107","article-title":"Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species","volume":"107","author":"Suzuki","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1002\/mc.23349","article-title":"Pharmacologic approaches to amino acid depletion for cancer therapy","volume":"61","author":"Wilder","year":"2022","journal-title":"Mol Carcinogenesis"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.4103\/0304-4920.365459","article-title":"Leonurine Suppresses Prostate Cancer Growth in vitro and in vivo by Regulating miR-18a-5p\/SLC40A1 Axis","volume":"65","author":"Liang","year":"2022","journal-title":"Chin J Physiol"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics10080549","article-title":"An update on the prognostic and predictive serum biomarkers in metastatic prostate cancer","volume":"10","author":"Saxby","year":"2020","journal-title":"Diagnostics"},{"key":"B216","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12894-018-0353-4","article-title":"Impact of early changes in serum biomarkers following androgen deprivation therapy on clinical outcomes in metastatic hormone-sensitive prostate cancer","volume":"18","author":"Sato","year":"2018","journal-title":"BMC Urol"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.345","article-title":"Plasma osteopontin as a biomarker of prostate cancer aggression: relationship to risk category and treatment response","volume":"107","author":"Thoms","year":"2012","journal-title":"Br J Cancer"},{"key":"B218","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1001\/jama.2017.7248","article-title":"The diagnosis and treatment of prostate cancer: A review","volume":"317","author":"Litwin","year":"2017","journal-title":"JAMA"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1002\/pros.24229","article-title":"Identification of the metabolic signatures of prostate cancer by mass spectrometry-based plasma and urine metabolomics analysis","volume":"81","author":"Yu","year":"2021","journal-title":"Prostate"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1080\/20013078.2018.1470442","article-title":"Metabolic alterations in urine extracellular vesicles are associated to prostate cancer pathogenesis and progression","volume":"7","author":"Clos-Garcia","year":"2018","journal-title":"J Extracellular Vesicle"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1172\/JCI148550","article-title":"Clinical development of metabolic inhibitors for oncology","volume":"132","author":"Lemberg","year":"2022","journal-title":"J Clin Invest"},{"key":"B222","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1158\/1535-7163.MCT-13-0870","article-title":"Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer","volume":"13","author":"Gross","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16162871","article-title":"Glutamine metabolism and prostate cancer","volume":"16","author":"Erb","year":"2024","journal-title":"Cancers"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22073315","article-title":"Mitochondrial fuel dependence on glutamine drives chemo-resistance in the cancer stem cells of hepatocellular carcinoma","volume":"22","author":"Lee","year":"2021","journal-title":"IJMS"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.1186\/1479-7364-3-3-281","article-title":"Human ATP-binding cassette (ABC) transporter family","volume":"3","author":"Vasiliou","year":"2008","journal-title":"Hum Genomics"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-13-0208","article-title":"Inhibition of ABCB1 expression overcomes acquired docetaxel resistance in prostate cancer","volume":"12","author":"Zhu","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-23-1105","article-title":"Metabolic reprogramming of tumor-associated macrophages using glutamine antagonist JHU083 drives tumor immunity in myeloid-rich prostate and bladder cancers","volume":"12","author":"Praharaj","year":"2024","journal-title":"Cancer Immunol Res"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abq5925","article-title":"Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug","volume":"8","author":"Rais","year":"2022","journal-title":"Sci Adv"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-1924","article-title":"Aldehyde dehydrogenase is regulated by \u03b2-catenin\/TCF and promotes radioresistance in prostate cancer progenitor cells","volume":"75","author":"Cojoc","year":"2015","journal-title":"Cancer Res"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.7150\/thno.88057","article-title":"ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and RAR-dependent transcription","volume":"14","author":"Gorodetska","year":"2024","journal-title":"Theranostics"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13184703","article-title":"The multifaceted role of aldehyde dehydrogenases in prostate cancer stem cells","volume":"13","author":"P\u00fcschel","year":"2021","journal-title":"Cancers"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.20517\/cdr.2020.54","article-title":"Metabolic reprogramming as an emerging mechanism of resistance to endocrine therapies in prostate cancer","volume":"4","author":"Chetta","year":"2021","journal-title":"CDR"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djt241","article-title":"Targeting amino acid transport in metastatic castration-resistant prostate cancer: effects on cell cycle, cell growth, and tumor development","volume":"105","author":"Wang","year":"2013","journal-title":"JNCI: J Natl Cancer Institute"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-22-0796","article-title":"Multi-substrate metabolic tracing reveals marked heterogeneity and dependency on fatty acid metabolism in human prostate cancer","volume":"21","author":"Fidelito","year":"2023","journal-title":"Mol Cancer Res"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.778761","article-title":"Personalized medicine for prostate cancer: is targeting metabolism a reality","volume":"11","author":"Fidelito","year":"2021","journal-title":"Front Oncol"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13010125","article-title":"Amino acid transporters on the guard of cell genome and epigenome","volume":"13","author":"Kahya","year":"2021","journal-title":"Cancers"},{"key":"B237","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s13402-020-00575-9","article-title":"Glutaminolysis is a metabolic route essential for survival and growth of prostate cancer cells and a target of 5\u03b1-dihydrotestosterone regulation","volume":"44","author":"Cardoso","year":"2021","journal-title":"Cell Oncol"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-17-1148","article-title":"We\u2019re not \u201cDON\u201d Yet: optimal dosing and prodrug delivery of 6-diazo-5-oxo-L-norleucine","volume":"17","author":"Lemberg","year":"2018","journal-title":"Mol Cancer Ther"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(195711\/12)10:6%253C1138::AID-CNCR2820100608%253E3.0.CO;2-K","article-title":"Pharmacological and initial therapeutic observations on 6-Diazo-5-Oxo-L-Norleucine (Don) in human neoplastic disease","volume":"10","author":"Magill","year":"1957","journal-title":"Cancer"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/22.2.433","article-title":"A CLINICAL study of the comparative effect of nitrogen mustard and DON in patients with bronchogenic carcinoma, Hodgkin\u2019s disease, lymphosarcoma, and melanoma","volume":"22","author":"Krantz","year":"1959","journal-title":"J Natl Cancer Inst"},{"key":"B241","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1001\/jama.1960.03030100059013","article-title":"Effects of combined drug therapy on metastatic cancer of the testis","volume":"174","author":"Li","year":"1960","journal-title":"JAMA"},{"key":"B242","first-page":"83","article-title":"A comparison of the effectiveness of standard dose 6-mercaptopurine, combination 6-mercaptopurine and DON, and high-loading 6-mercaptopurine therapies in treatment of the acute leukemias of childhood: results of a coperative study","volume":"18","author":"Sullivan","year":"1962","journal-title":"Cancer Chemother Rep"},{"key":"B243","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/BF00262746","article-title":"Pharmacokinetic and phase I study of intravenous DON (6-diazo-5-oxo-L-norleucine) in children, Cancer Chemother","volume":"21","author":"Sullivan","year":"1988","journal-title":"Pharmacol"},{"key":"B244","article-title":"Phase I trial of 6-diazo-5-oxo-L-norleucine (DON) administered by 5-day courses","volume":"66","author":"Earhart","year":"1982","journal-title":"Cancer Treat Rep"},{"key":"B245","article-title":"Phase I study of 6-diazo-5-oxo-L-norleucine (DON)","volume":"64","author":"Sklaroff","year":"1980","journal-title":"Cancer Treat Rep"},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20070039","article-title":"Novel mechanism of inhibition of rat kidney-type glutaminase by bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES)","volume":"406","author":"Robinson","year":"2007","journal-title":"Biochem J"},{"key":"B247","doi-asserted-by":"publisher","DOI":"10.3109\/14756366.2011.622272","article-title":"BPTES inhibition of hGA(124-551), a truncated form of human kidney-type glutaminase","volume":"27","author":"Hartwick","year":"2012","journal-title":"J Enzyme Inhib Med Chem"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1112495109","article-title":"Mitochondrial localization and structure-based phosphate activation mechanism of Glutaminase C with implications for cancer metabolism, Proc","volume":"109","author":"Cassago","year":"2012","journal-title":"Natl Acad Sci USA"},{"key":"B249","doi-asserted-by":"publisher","DOI":"10.1021\/bi201613d","article-title":"Full-length human glutaminase in complex with an allosteric inhibitor","volume":"50","author":"DeLaBarre","year":"2011","journal-title":"Biochemistry"},{"key":"B250","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-020-0195-8","article-title":"Identifying strategies to target the metabolic flexibility of tumours","volume":"2","author":"M\u00e9ndez-Lucas","year":"2020","journal-title":"Nat Metab"},{"key":"B251","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15965","article-title":"Compensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolism","volume":"8","author":"Biancur","year":"2017","journal-title":"Nat Commun"},{"key":"B252","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA119.008180","article-title":"Dual inhibition of glutaminase and carnitine palmitoyltransferase decreases growth and migration of glutaminase inhibition\u2013resistant triple-negative breast cancer cells","volume":"294","author":"Reis","year":"2019","journal-title":"J Biol Chem"},{"key":"B253","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.ccell.2018.04.002","article-title":"The GSK3 signaling axis regulates adaptive glutamine metabolism in lung squamous cell carcinoma","volume":"33","author":"Momcilovic","year":"2018","journal-title":"Cancer Cell"},{"key":"B254","doi-asserted-by":"publisher","DOI":"10.1172\/JCI78239","article-title":"Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment","volume":"125","author":"Tanaka","year":"2015","journal-title":"J Clin Invest"},{"key":"B255","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e31818b0d9b","article-title":"Is cancer a disease of abnormal cellular metabolism? New angles on an old idea","volume":"10","author":"Deberardinis","year":"2008","journal-title":"Genet Med"},{"key":"B256","doi-asserted-by":"publisher","DOI":"10.1126\/science.1164382","article-title":"An integrated genomic analysis of human glioblastoma multiforme","volume":"321","author":"Parsons","year":"2008","journal-title":"Science"},{"key":"B257","doi-asserted-by":"publisher","DOI":"10.1002\/path.4547","article-title":"A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy","volume":"236","author":"Pertega-Gomes","year":"2015","journal-title":"J Pathol"},{"key":"B258","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2017.00131","article-title":"The metabolic phenotype of prostate cancer","volume":"7","author":"Eidelman","year":"2017","journal-title":"Front Oncol"},{"key":"B259","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2017.00097","article-title":"Glucose metabolism in the progression of prostate cancer","volume":"8","author":"Cutruzzol\u00e0","year":"2017","journal-title":"Front Physiol"},{"key":"B260","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat Med"},{"key":"B261","doi-asserted-by":"publisher","DOI":"10.1172\/JCI83871","article-title":"Cancer immunotherapy: harnessing the immune system to battle cancer","volume":"125","author":"Yang","year":"2015","journal-title":"J Clin Invest"},{"key":"B262","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0304-3940(93)90134-7","article-title":"Response of rat cerebral glycolytic enzymes to hyperammonemic states","volume":"161","author":"Ratnakumari","year":"1993","journal-title":"Neurosci Lett"},{"key":"B263","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1152\/physrev.1987.67.2.440","article-title":"Biochemistry and physiology of brain ammonia","volume":"67","author":"Cooper","year":"1987","journal-title":"Physiol Rev"},{"key":"B264","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.101753","article-title":"Inhibitor of glutamine metabolism V9302 promotes ROS-induced autophagic degradation of B7H3 to enhance antitumor immunity","volume":"298","author":"Li","year":"2022","journal-title":"J Biol Chem"},{"key":"B265","doi-asserted-by":"publisher","DOI":"10.1002\/pros.23742","article-title":"M2 macrophages and regulatory T cells in lethal prostate cancer","volume":"79","author":"Erlandsson","year":"2019","journal-title":"Prostate"},{"key":"B266","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00005-021-00633-6","article-title":"The role of non-essential amino acids in T cell function and anti-tumour immunity, arch","volume":"69","author":"Hope","year":"2021","journal-title":"Immunol Ther Exp"},{"key":"B267","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22105207","article-title":"Inhibition of the PI3K\/mTOR pathway in breast cancer to enhance response to immune checkpoint inhibitors in breast cancer","volume":"22","author":"Yan","year":"2021","journal-title":"IJMS"},{"key":"B268","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.semcancer.2014.01.005","article-title":"Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth","volume":"25","author":"Martinez-Outschoorn","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"B269","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12020461","article-title":"L-DOS47 elevates pancreatic cancer tumor pH and enhances response to immunotherapy","volume":"12","author":"Jardim-Perassi","year":"2024","journal-title":"Biomedicines"},{"key":"B270","doi-asserted-by":"publisher","DOI":"10.3390\/ijms161226138","article-title":"Non-coding RNAs in castration-resistant prostate cancer: regulation of androgen receptor signaling and cancer metabolism","volume":"16","author":"Shih","year":"2015","journal-title":"IJMS"},{"key":"B271","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2015.07.001","article-title":"Metabolomic profiling of hormone-dependent cancers: a bird\u2019s eye view","volume":"26","author":"Lloyd","year":"2015","journal-title":"Trends Endocrinol Metab"},{"key":"B272","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2012748118","article-title":"A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer","volume":"118","author":"Xu","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"B273","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11030139","article-title":"Resistance to androgen deprivation leads to altered metabolism in human and murine prostate cancer cell and tumor models","volume":"11","author":"Sun","year":"2021","journal-title":"Metabolites"},{"key":"B274","doi-asserted-by":"publisher","DOI":"10.1021\/pr401106h","article-title":"Metabolomic profiling identifies biochemical pathways associated with castration-resistant prostate cancer","volume":"13","author":"Kaushik","year":"2014","journal-title":"J Proteome Res"},{"key":"B275","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2021.1962682","article-title":"Targeting glutamine metabolism and autophagy: the combination for prostate cancer radiosensitization","volume":"17","author":"Mukha","year":"2021","journal-title":"Autophagy"},{"key":"B276","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/iju.13473","article-title":"Metabolic changes in patients with prostate cancer during androgen deprivation therapy","volume":"25","author":"Mitsuzuka","year":"2018","journal-title":"Int J Urol"},{"key":"B277","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.13071","article-title":"Emerging methods for prostate cancer imaging: evaluating cancer structure and metabolic alterations more clearly","volume":"15","author":"Retter","year":"2021","journal-title":"Mol Oncol"},{"key":"B278","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1148\/radiol.09090475","article-title":"Prostate cancer: value of multiparametric MR imaging at 3 T for detection\u2014Histopathologifc correlation","volume":"255","author":"Turkbey","year":"2010","journal-title":"Radiology"},{"key":"B279","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13244-019-0703-0","article-title":"How clinical imaging can assess cancer biology","volume":"10","author":"Garc\u00eda-Figueiras","year":"2019","journal-title":"Insights Imaging"},{"key":"B280","doi-asserted-by":"publisher","DOI":"10.4103\/1450-1147.176882","article-title":"The pearl of FDG PET\/CT in preoperative assessment of patients with potentially operable non-small-cell lung cancer and its clinical impact","volume":"16","author":"Kung","year":"2017","journal-title":"World J Nucl Med"},{"key":"B281","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00330-006-0284-4","article-title":"Additional value of PET-CT in the staging of lung cancer: comparison with CT alone, PET alone and visual correlation of PET and CT","volume":"17","author":"De Wever","year":"2007","journal-title":"Eur Radiol"},{"key":"B282","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2903-7","article-title":"Prognostic value of volumetric parameters of 18F-FDG PET in non-small-cell lung cancer: a meta-analysis","volume":"42","author":"Im","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B283","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2019182391","article-title":"Hyperpolarized13 C MRI: state of the art and future directions","volume":"291","author":"Wang","year":"2019","journal-title":"Radiology"},{"key":"B284","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25105071","article-title":"Metabolomics and proteomics in prostate cancer research: overview, analytical techniques, data analysis, and recent clinical applications","volume":"25","author":"Al-Daffaie","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B285","doi-asserted-by":"publisher","DOI":"10.1038\/srep44602","article-title":"The metabolic waste ammonium regulates mTORC2 and mTORC1 signaling","volume":"7","author":"Merhi","year":"2017","journal-title":"Sci Rep"},{"key":"B286","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.184826","article-title":"SLC4A11 mediates ammonia import and promotes cancer stemness in hepatocellular carcinoma","volume":"9","author":"Elaimy","year":"2024","journal-title":"JCI Insight"},{"key":"B287","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-24-0749","article-title":"Ammonia suppresses the antitumor activity of natural killer cells and T cells by decreasing mature perforin","volume":"85","author":"Domagala","year":"2025","journal-title":"Cancer Res"},{"key":"B288","doi-asserted-by":"publisher","DOI":"10.1007\/s002400050166","article-title":"Ammonium-chloride-induced prostatic hypertrophy in vitro: urinary ammonia as a potential risk factor for benign prostatic hyperplasia","volume":"27","author":"Won","year":"1999","journal-title":"Urological Res"},{"key":"B289","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00429","article-title":"Physiological role of glutamate dehydrogenase in cancer cells, front","volume":"10","author":"Moreno-S\u00e1nchez","year":"2020","journal-title":"Oncol"},{"key":"B290","unstructured":"A phase II Study of the Glutaminase Inhibitor Telaglenastat (CB-839) in Combination With the PARP Inhibitor Talazoparib in Participants With Metastatic Castration-Resistant Prostate Cancer\n          \n          \n          2021"},{"key":"B291","unstructured":"Ph1 Study of the Safety, PK, and PDn of Escalating Oral Doses of the Glutaminase Inhibitor CB-839, as a Single Agent and in Combination With Standard Chemotherapy in Patients With Advanced and\/or Treatment-Refractory Solid Tumors\n          \n          \n          2014"},{"key":"B292","unstructured":"A Phase 1b\/2, Open Label, Dose Escalation and Expansion Study of the Glutaminase Inhibitor Telaglenastat (CB-839) in Combination With CDK4\/6 Inhibitor Palbociclib in Patients With Advanced or Metastatic Solid Tumors\n          \n          \n          2019"},{"key":"B293","unstructured":"A Phase 1b\/2 Open Label, Dose Escalation and Expansion Study of the Glutaminase Inhibitor CB-839 in Combination With the PARP Inhibitor Talazoparib in Patients With Advanced or Metastatic Solid Tumors\n          \n          \n          2019"},{"key":"B294","unstructured":"Phase 1 and Phase 2a, First-in-human Study of DRP-104, a Glutamine Antagonist, in Adult Patients With Advanced Solid Tumors\n          \n          \n          2020"},{"key":"B295","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.671902","article-title":"Pharmacological vitamin C treatment impedes the growth of endogenous glutamine-dependent cancers by targeting glutamine synthetase","volume":"12","author":"Long","year":"2021","journal-title":"Front Pharmacol"},{"key":"B296","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00330.2006","article-title":"ASCT2 silencing regulates mammalian target-of-rapamycin growth and survival signaling in human hepatoma cells","volume":"293","author":"Fuchs","year":"2007","journal-title":"Am J Physiology-Cell Physiol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1673513\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T04:18:13Z","timestamp":1760588293000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1673513\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":296,"alternative-id":["10.3389\/fonc.2025.1673513"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1673513","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,16]]},"article-number":"1673513"}}